EUVIMEDEUVIMED entdecken
Vergleichsstudie

Clinical Outcomes of Comparison Between Type III Coronary Artery Perforation (CAP) and non-CAP Acute Coronary Syndrome Patients During 3-Year Follow-up

Bekir S Yildiz iD, Ramazan Gunduz iD, Su Ozgur, Ahmet Y Cizgici, Ibrahim H Ozdemir

Angiology · 2025

DOI: 10.1177/00033197231200029 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Angiology, 2025. Verfasst von Bekir S Yildiz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Celal Bayar University, Manisa, Turkey. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Percutaneous Coronary Intervention, Coronary Vessels. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronary artery perforation (CAP) is a potentially fatal complication of percutaneous coronary intervention (PCI) in acute coronary syndrome (ACS). This study aimed to investigate in-hospital, 1-year, and 3-year clinical outcomes of type III CAP during PCI in patients with ACS. The study retrospectively evaluated 118 patients with CAP and 43,226 case-control patients. Clinical, angiographic, and procedural characteristics, management, and outcomes were analyzed retrospectively at 1-year and 3-year follow-ups. The mean age of the patients was 66.5 ± 11.9 years (61.8% males). There was no significant difference in hospital mortality between the type III CAP and non-CAP groups. The all-cause mortality was 33.3% in the CAP group vs 1.8% in the non-CAP group at 1 year, and 28.3% in CAP group vs 6.9% in non-CAP group at 3 years ( p = .001 for both comparisons). The procedural, clinical, and 1 and 3-year outcomes of type III CAP showed a relatively high risk of myocardial infarction, coronary artery bypass graft, cerebrovascular event, stent thrombosis, and major bleeding at the 1 and 3-year follow-ups. In addition, non-CAP ACS patients had better survival (log-rank: p < .001, 34.29 months 95% Confidence Interval [33.58–35.00]) than type III CAP ACS patients (29.53 months 95% Confidence Interval [27.28–31.78]) at the 3-year follow-up visit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromePercutaneous Coronary InterventionCoronary VesselsHumansMaleFemaleAgedRetrospective StudiesMiddle AgedTreatment OutcomeRisk FactorsTime FactorsFollow-Up StudiesCoronary AngiographyCase-Control StudiesHospital Mortality

Stichwörter der Autor:innen

3-year follow-upacute coronary syndromecoronary artery perforation

Autor:innen und Institutionen

  • Department of Cardiology, Celal Bayar University, Manisa, Turkey.
  • Department of Cardiology, Manisa City Hospital, Manisa, Turkey.
  • Department of Biostatistics and Medical Informatics, Ege University, Izmir, Turkey.
  • Department of Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training Research Hospital, Istanbul, Turkey.

ORCID-Profile: Bekir S Yildiz, Ramazan Gunduz

Zitieren

APA

Yildiz, B. S., Gunduz, R., Ozgur, S., Cizgici, A. Y., & Ozdemir, I. H. (2025). Clinical Outcomes of Comparison Between Type III Coronary Artery Perforation (CAP) and non-CAP Acute Coronary Syndrome Patients During 3-Year Follow-up. Angiology. https://doi.org/10.1177/00033197231200029

Vancouver

Yildiz BS, Gunduz R, Ozgur S, Cizgici AY, Ozdemir IH. Clinical Outcomes of Comparison Between Type III Coronary Artery Perforation (CAP) and non-CAP Acute Coronary Syndrome Patients During 3-Year Follow-up. Angiology. 2025. doi:10.1177/00033197231200029

BibTeX
@article{Yildiz2025,
  author = {Yildiz, Bekir S and Gunduz, Ramazan and Ozgur, Su and Cizgici, Ahmet Y and Ozdemir, Ibrahim H},
  title = {Clinical Outcomes of Comparison Between Type III Coronary Artery Perforation (CAP) and non-CAP Acute Coronary Syndrome Patients During 3-Year Follow-up},
  journal = {Angiology},
  year = {2025},
  doi = {10.1177/00033197231200029}
}
Kostenlos starten →